ATH 33.3% 0.4¢ alterity therapeutics limited

Somebody invested US$ 3, page-3

  1. 2,840 Posts.
    lightbulb Created with Sketch. 995
    Life Science held as of the 26th of Aug 6.08% of the shares, nobody else had over 5%.

    Annual report, p 59:

    There are no other shareholders known to us who own beneficially more than 5% of our ordinary shares.
    Significant Changes in the Ownership of Major Shareholders
    There have been no other significant changes in the ownership of major shareholders during the year.
    Major Shareholders Voting Rights
    A major shareholder would not have different voting rights.
    Record Holders
    As of August 26, 2022, there were 5,590 holders of record of our ordinary shares, of which 22 record holders, holding approximately 59.09% of
    our ordinary shares, had registered addresses in the United States. These numbers are not representative of the number of beneficial holders of our shares
    nor are they representative of where such beneficial holders reside, since many of these ordinary shares were held of record by brokers or other nominees.
    The majority of trading by our U.S. investors is done by means of ADSs that are held of record by HSBC Custody Nominees Ltd., which held 58.75% of
    our ordinary shares including 6.08% holding by Life Biosciences LLC as of such date
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.